The rising price issues will pose the greatest hindrance to the medical cannabis industry in the coming weeks. CEO of Lio Pharmaceuticals and German distributor Alain Menghé à Menghé does not believe these recent hostilities won’t impact the entire industry. Menghé is currently building a manufacturing plant in Solingen, Dusseldorf.
Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10.…
From robot canopy scanners to algorithmic breeders to AI-powered dispensary counters, artificial intelligence is remaking…
The latest version of this story comes from Virginia Commonwealth University, where researcher Emanuele Alves…
But there's more to this image than nostalgia and comedy. What you're looking at in…
The league pulled marijuana off its banned list in the new players’ agreement. In the…
In New South Wales, Australia, patients can legally use medical cannabis with a prescription. So…